Giovanni Balato1, Emanuela Roscetto2, Adriana Vollaro2, Olimpio Galasso3, Giorgio Gasparini3, Tiziana Ascione4, Maria Rosaria Catania2, Massimo Mariconda5. 1. Section of Orthopaedic Surgery, Department of Public Health, School of Medicine, Federico II University, Naples. Via S. Pansini 5, 80131, Naples, Italy. giovannibalato@gmail.com. 2. Department of Molecular Medicine and Medical Biotechnology, Federico II University, Naples, Italy. 3. Division of Orthopaedic and Trauma Surgery, Department of Medical and Surgical Sciences, "Magna Graecia" University, Catanzaro, Italy. 4. Department of Infectious Disease, AORN dei Colli, Naples, Italy. 5. Section of Orthopaedic Surgery, Department of Public Health, School of Medicine, Federico II University, Naples. Via S. Pansini 5, 80131, Naples, Italy.
Abstract
PURPOSE: The aim of the present study was to quantitatively assess biofilm growth on the surface of bone cements discs containing different antibiotics, including colistin and linezolid. Biofilms of methicillin-resistant Staphylococcus aureus (MRSA), Pseudomonas aeruginosa, and Staphylococcus epidermidis were grown on bone cement discs for 96 h. METHODS: Biofilm amounts were measured by confocal laser microscopy using live/dead staining and dedicated software at different time intervals (48, 72, and 96 h). RESULTS: Bone cement containing vancomycin was not effective at reducing MRSA biofilm formation 96 h following bacterial inoculation. At a comparable time interval, linezolid-, clindamycin-, and aminoglycoside-loaded cement was still active against this biofilm. At the 72- and 96-h observations, S. epidermidis biofilm was present only on tobramycin and gentamicin discs. P. aeruginosa biofilms were present on cement discs loaded with colistin at all time intervals starting from the 48-h observation, whereas no biofilms were detected on tobramycin or gentamicin discs. CONCLUSION: Bone cements containing different antibiotics have variable and time-dependent windows of activity in inhibiting or reducing surface biofilm formation. The effectiveness of bone cement containing vancomycin against MRSA biofilm is questionable. The present study is clinically relevant, because it suggests that adding the right antibiotic to bone cement could be a promising approach to treat periprosthetic infections. Indeed, the antibiofilm activity of different antibiotic-loaded bone cements could be preoperatively assessed using the current methodology in two-stage exchange procedures.
PURPOSE: The aim of the present study was to quantitatively assess biofilm growth on the surface of bone cements discs containing different antibiotics, including colistin and linezolid. Biofilms of methicillin-resistant Staphylococcus aureus (MRSA), Pseudomonas aeruginosa, and Staphylococcus epidermidis were grown on bone cement discs for 96 h. METHODS: Biofilm amounts were measured by confocal laser microscopy using live/dead staining and dedicated software at different time intervals (48, 72, and 96 h). RESULTS: Bone cement containing vancomycin was not effective at reducing MRSA biofilm formation 96 h following bacterial inoculation. At a comparable time interval, linezolid-, clindamycin-, and aminoglycoside-loaded cement was still active against this biofilm. At the 72- and 96-h observations, S. epidermidis biofilm was present only on tobramycin and gentamicin discs. P. aeruginosa biofilms were present on cement discs loaded with colistin at all time intervals starting from the 48-h observation, whereas no biofilms were detected on tobramycin or gentamicin discs. CONCLUSION: Bone cements containing different antibiotics have variable and time-dependent windows of activity in inhibiting or reducing surface biofilm formation. The effectiveness of bone cement containing vancomycin against MRSA biofilm is questionable. The present study is clinically relevant, because it suggests that adding the right antibiotic to bone cement could be a promising approach to treat periprosthetic infections. Indeed, the antibiofilm activity of different antibiotic-loaded bone cements could be preoperatively assessed using the current methodology in two-stage exchange procedures.
Authors: Daniëlle Neut; Johannes G E Hendriks; Jim R van Horn; Henny C van der Mei; Henk J Busscher Journal: Acta Orthop Date: 2005-02 Impact factor: 3.717
Authors: D Neut; H van de Belt; I Stokroos; J R van Horn; H C van der Mei; H J Busscher Journal: J Antimicrob Chemother Date: 2001-06 Impact factor: 5.790
Authors: Paloma Anguita-Alonso; Mark S Rouse; Kerryl E Piper; David J Jacofsky; Douglas R Osmon; Robin Patel Journal: Clin Orthop Relat Res Date: 2006-04 Impact factor: 4.176
Authors: Marco Balato; Carlo Petrarca; Antonio Quercia; Aniello Riccio; Andrea Sellitto; Jessica Campi; Anna Borriello; Mauro Zarrelli; Giovanni Balato Journal: Polymers (Basel) Date: 2021-11-23 Impact factor: 4.329
Authors: Emanuela Roscetto; Marco Masi; Matilde Esposito; Roberta Di Lecce; Antonella Delicato; Lucia Maddau; Viola Calabrò; Antonio Evidente; Maria Rosaria Catania Journal: Toxins (Basel) Date: 2020-07-08 Impact factor: 4.546